Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ukraine
Biotech
Checkpoint ends combo drug trial, citing war in Ukraine
Checkpoint is calling it quits on a phase 3 combo trial of its cancer med because of enrollment problems stemming from the war in Ukraine.
Max Bayer
Aug 12, 2022 12:16pm
Intrivo CEO calls medtech startups to action to help Ukraine
Jun 17, 2022 9:35am
Why the war in Ukraine might make root canals more difficult
Jun 3, 2022 9:40am
Eli Lilly does victory lap with UC data after COVID disruptions
May 24, 2022 3:01am
Siemens Healthineers to stay in Russia, as Siemens AG departs
May 12, 2022 2:55pm
Sanofi moves MS patients out of Ukraine to maintain trial
Apr 29, 2022 8:20am
